Ian Reed

From SourceWatch
Jump to navigation Jump to search

{{#badges:AEX}}

Ian Reed is the CEO of Pfizer Inc. He had an annual compensation of $17.4 million in 2010.

Ties to the American Legislative Exchange Council

Pfizer is on the Corporate ("Private Enterprise") Board of the American Legislative Exchange Council (ALEC) as of 2011. [1]

About ALEC
ALEC is a corporate bill mill. It is not just a lobby or a front group; it is much more powerful than that. Through ALEC, corporations hand state legislators their wishlists to benefit their bottom line. Corporations fund almost all of ALEC's operations. They pay for a seat on ALEC task forces where corporate lobbyists and special interest reps vote with elected officials to approve “model” bills. Learn more at the Center for Media and Democracy's ALECexposed.org, and check out breaking news on our PRWatch.org site.

Background

Pfizer Inc is a global, multinational pharmaceutical company founded in 1851. It is the world's largest research-based pharmaceuticals corporation. Brand names include erectile dysfunction drug Viagra, pain management drug Celebrex, high-blood-pressure drug Norvasc, and cholesterol drug Lipitor. The company also manufactures animal care products such as Revolution, an anti-parasitic. Pfizer markets its pharmaceuticals directly to health care providers and patients. The majority of its' sales are conducted through the wholesale companies McKesson and Cardinal Health.

Articles and resources

Related SourceWatch articles

References

  1. Private Enterprise Board, ALEC website, accessed July 7, 2011.

External resources

External articles

This article is a stub. You can help by expanding it.